ArticleFrontiers in psychiatry2026

Postmarketing surveillance of elobixibat for patients with chronic constipation and concomitant schizophrenia or depression in Japan.

Yoshiteru Takekita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.